AD-224
/ Yuhan Corp
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
August 04, 2026
A Study to Evaluate the Efficacy and Safety of AD-224
(clinicaltrials.gov)
- P3 | N=254 | Completed | Sponsor: Addpharma Inc. | Recruiting ➔ Completed
Trial completion • Cardiovascular • Hypertension
February 04, 2025
A Study to Evaluate the Efficacy and Safety of AD-224
(clinicaltrials.gov)
- P3 | N=252 | Recruiting | Sponsor: Addpharma Inc. | Trial completion date: Dec 2024 ➔ Jul 2025 | Trial primary completion date: Dec 2024 ➔ Jul 2025
Trial completion date • Trial primary completion date • Cardiovascular • Hypertension
August 01, 2024
A Study to Evaluate the Efficacy and Safety of AD-224
(clinicaltrials.gov)
- P3 | N=252 | Recruiting | Sponsor: Addpharma Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Hypertension
March 04, 2024
A Study to Evaluate the Efficacy and Safety of AD-224
(clinicaltrials.gov)
- P3 | N=252 | Not yet recruiting | Sponsor: Addpharma Inc.
New P3 trial • Cardiovascular • Hypertension
1 to 4
Of
4
Go to page
1